Antihypertensive Drugs Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis and Forecast 2020-2027

According to Vision Research Reports, the global antihypertensive drugs market size surpassed at US$ 28 billion in 2019 and to reach US$ 34 billion by 2027 with a CAGR of 2.3% from 2020 to 2027. Rise in prevalence of geriatric population is expected to increase at a rapid pace in the next few years.

Stroke, also known as cerebrovascular accident, is a medical condition that occurs when the blood supply to the brain is interrupted or blocked. It leads to sudden death of brain cells due to lack of oxygen, which takes place as a result of a rupture of the artery or vein that carries blood to the brain.

Increase in incidence rate of cardiovascular diseases, owing to changing demographics and rise in prevalence of stroke, diabetes, and hypertension patients is expected to drive the antihypertensive drugs market

North America held a major share of the global antihypertensive drugs market in 2019, due to the presence of a large population with the history of diabetes, blood pressure related diseases, stroke, rise in mortality associated with the disease, and increase in research funding for antihypertensive drugs in the U.S.

The antihypertensive drugs market in Asia Pacific is expected to expand at a CAGR of 3% from 2020 to 2027 due to surge in the number of elderly patients and increase in cardiovascular disorders in patients suffering from hypertension. This, in turn, is likely to drive the demand for antihypertensive drugs in emerging markets such as India and China.

Rise in Prevalence of Stroke to Drive Antihypertensive Drugs Market

  • The global geriatric population is projected to increase at a rapid pace over the next few years. Declining fertility and improved longevity are prominent factors for rise in the geriatric population.
  • Rise in aging population globally is projected to drive the global antihypertensive drugs market during the forecast period
  • For instance, the geriatric population in developing regions is estimated to increase by 154% between 2017 and 2050, exceeding 1.6 billion by 2050. Furthermore, an increase in the number of baby boomers vulnerable to a wide range of age-related diseases has been observed.
  • Age is a primary risk factor for hypertension. Prevalence of hypertension is comparatively high in the elderly population; approximately 70% of high blood pressure patients are over the age of 60. Additionally, aging increases blood pressure, as elasticity of the arterial system is reduced. Hence, rise in prevalence of hypertension among the population is projected to drive the antihypertensive drugs market over the next few years.

High Demand for Angiotensin Receptor Blockers

  • In terms of drug, the global antihypertensive drugs market has been segmented into diuretics, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, vasodilators, calcium channel blockers, renin inhibitors, alpha-blockers, and others. The diuretics segment has been sub-segmented into thiazide diuretic, loop diuretics, and potassium-sparing diuretics. The beta-blockers segment has been sub-segmented into beta-1 selective and intrinsic sympathomimetic.
  • The angiotensin receptor blockers segment dominated the market in 2019 and this trend is expected to continue during the forecast period
  • Rapid adoption and rise in demand for angiotensin receptor blockers have been observed in the recent years, as these are one of the trusted drugs. Additionally, rise in prevalence of hypertension and continually increasing expenses of its treatment influence the prescribing patterns among physicians and compliance to the treatment by the patients. These are expected to drive the segment.

Primary Hypertension a Key Market Driver

  • In terms of condition, the global antihypertensive drugs market has been classified into primary hypertension and secondary hypertension
  • The primary hypertension segment accounted for major market share in 2019; the trend is expected to continue during the forecast period. Hypertension has become a global health problem in the past decade. In the developed world, salt intake is generally above the recommended quantity among children and a similar trend exists in the developing world.
  • Most of the people suffer from primary hypertension. Prevalence of secondary hypertension and the most common etiologies vary with age. Approximately 5% to 10% adults with hypertension have a secondary cause.

Greater Effect of Combination Therapy on Hypertension

  • Based on medication type, the global antihypertensive drugs market has been categorized into monotherapy, combination therapy, and fixed dose combinations
  • By combining two drugs with different mechanisms of action, an antihypertensive effect of two to five times greater than that obtained by monotherapy is possible. In some of the cases, patients who are treated with existing monotherapies fail to achieve target blood pressure. These are the factors which are expected to drive the global antihypertensive drugs market during the forecast period.

Hospital Pharmacies Dominates Antihypertensive Drugs Market

  • In terms of distribution channel, the antihypertensive drugs market has been categorized into retail pharmacies, hospital pharmacies, online pharmacies, and others
  • The hospital pharmacies segment held a major share of the global antihypertensive drugs market in 2019. Growth of this segment can be attributed to a surge in new cases of stroke and myocardial infarction across the globe and patient preference for treatment in hospitals.

Asia Pacific to Offer Significant Growth Opportunities

  • In terms of region, the global antihypertensive drugs market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa
  • The antihypertensive drugs market in Asia Pacific is projected to grow at a rapid pace in the near future. India and China are anticipated to be lucrative markets for antihypertensive drugs during the forecast period, owing to high prevalence of cardiac diseases, unhealthy lifestyle choices, such as smoking, poor diet, and high incidence of diabetes and hypertension, which may fuel the risk of a stroke.
  • North America is projected to account for a leading share of the global antihypertensive drugs market during the forecast period, owing to increase in incidence rate of cardiovascular diseases, particularly, in the U.S.
  • High disposable income of the patient population contributes to the growth of the antihypertensive drugs market in the region. Increase in disposable income drives the uptake of medical and other related services.
  • Hypertension is a condition which was recognized in the U.S. much ahead of other regions and antihypertensive drugs were also sold in the country quite early. Furthermore, cases of a number of individuals taking these drugs as a preventive measure have been reported. This, in turn, is expected to drive the demand for antihypertensive drugs in the country
  • Favorable funding by government and charitable trusts for stroke research, prevention, and treatment in the U.S. are likely to drive the antihypertensive drugs market in North America

Growth Strategies of Key Players

  • Key players operating in the global antihypertensive drugs market include Pfizer, Inc., Sanofi S.A., Novartis AG, AstraZeneca plc, and Boehringer Ingelheim GmbH
  • These companies are engaging in research & development activities to develop novel products in order to expand product offerings and customer base. For instance, Johnson & Johnson focuses on joint collaboration with leading research institutes, biotech & pharmaceutical companies, and government and non-profit organizations for the development of novel therapeutic products and technologies in different areas. Janssen Biotech, subsidiary of Johnson & Johnson, has more than 150 collaborations across the world in all aspects of healthcare.

Market Segmentation

Antihypertensive Drugs Market, by Drug

  • Diuretics
    • Thiazide Diuretics
    • Loop Diuretics
    • Potassium-sparing Diuretics
  • Angiotensin Converting Enzyme Inhibitors
  • Angiotensin Receptor Blockers
  • Beta-blockers
    • Beta-1 Selective
    • Intrinsic Sympathomimetic
  • Vasodilators
  • Calcium Channel Blockers
  • Renin Inhibitors
  • Alpha-blockers
  • Others 

Antihypertensive Drugs Market, by Condition

  • Primary Hypertension
  • Secondary Hypertension

Antihypertensive Drugs Market, by Medication Type

  • Monotherapy
  • Combination Therapy
  • Fixed Dose Combinations

Antihypertensive Drugs Market, by Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Others

Antihypertensive Drugs Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Report Scope

The Antihypertensive drugs market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Antihypertensive drugs market for the base year 2019 and the forecast between 2020 and 2027. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Antihypertensive drugs market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antihypertensive drugs market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Antihypertensive drugs market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Antihypertensive drugs capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Antihypertensive drugs by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Antihypertensive drugs market. These figures have been provided in terms of both revenue and volume for the period 2016 to 2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Antihypertensive drugs market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Antihypertensive drugs market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Antihypertensive drugs industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Antihypertensive drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Antihypertensive drugs market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Antihypertensive drugs market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Antihypertensive drugs market. These factors have benefited the growth of the global market for Antihypertensive drugs. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Antihypertensive drugs. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Antihypertensive drugs are as follows:

  • History Year: 2016-2019
  • Base Year: 2020
  • Forecast Year 2020 to 2027

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2016-2019) and forecast (2020-2027);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Report Detail

Proceed To Buy

USD 4500
USD 7900

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers